Literature DB >> 19478221

Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association.

Gregory J Del Zoppo, Jeffrey L Saver, Edward C Jauch, Harold P Adams.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19478221      PMCID： PMC2782817          DOI： 10.1161/STROKEAHA.109.192535

Source DB:  PubMed          Journal:  Stroke        ISSN： 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  12 in total

1.  Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.

Authors:  W M Clark; S Wissman; G W Albers; J H Jhamandas; K P Madden; S Hamilton
Journal:  JAMA       Date:  1999-12-01       Impact factor: 56.272

2.  Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke.

Authors:  G J del Zoppo; K Poeck; M S Pessin; S M Wolpert; A J Furlan; A Ferbert; M J Alberts; J A Zivin; L Wechsler; O Busse
Journal:  Ann Neurol       Date:  1992-07       Impact factor: 10.422

3.  Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke.

Authors:  E Mori; Y Yoneda; M Tabuchi; T Yoshida; S Ohkawa; Y Ohsumi; K Kitano; A Tsutsumi; A Yamadori
Journal:  Neurology       Date:  1992-05       Impact factor: 9.910

4.  The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g) : results of a double-blind, placebo-controlled, multicenter study. Thromblytic therapy in acute ischemic stroke study investigators.

Authors:  W M Clark; G W Albers; K P Madden; S Hamilton
Journal:  Stroke       Date:  2000-04       Impact factor: 7.914

5.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

6.  Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.

Authors:  Werner Hacke; Markku Kaste; Erich Bluhmki; Miroslav Brozman; Antoni Dávalos; Donata Guidetti; Vincent Larrue; Kennedy R Lees; Zakaria Medeghri; Thomas Machnig; Dietmar Schneider; Rüdiger von Kummer; Nils Wahlgren; Danilo Toni
Journal:  N Engl J Med       Date:  2008-09-25       Impact factor: 91.245

7.  Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study.

Authors:  Nils Wahlgren; Niaz Ahmed; Antoni Dávalos; Werner Hacke; Mónica Millán; Keith Muir; Risto O Roine; Danilo Toni; Kennedy R Lees
Journal:  Lancet       Date:  2008-09-12       Impact factor: 79.321

8.  Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

Authors:  W Hacke; M Kaste; C Fieschi; R von Kummer; A Davalos; D Meier; V Larrue; E Bluhmki; S Davis; G Donnan; D Schneider; E Diez-Tejedor; P Trouillas
Journal:  Lancet       Date:  1998-10-17       Impact factor: 79.321

9.  Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials.

Authors:  Werner Hacke; Geoffrey Donnan; Cesare Fieschi; Markku Kaste; Rüdiger von Kummer; Joseph P Broderick; Thomas Brott; Michael Frankel; James C Grotta; E Clarke Haley; Thomas Kwiatkowski; Steven R Levine; Chris Lewandowski; Mei Lu; Patrick Lyden; John R Marler; Suresh Patel; Barbara C Tilley; Gregory Albers; Erich Bluhmki; Manfred Wilhelm; Scott Hamilton
Journal:  Lancet       Date:  2004-03-06       Impact factor: 79.321

10.  Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

Authors:  W Hacke; M Kaste; C Fieschi; D Toni; E Lesaffre; R von Kummer; G Boysen; E Bluhmki; G Höxter; M H Mahagne
Journal:  JAMA       Date:  1995-10-04       Impact factor: 56.272
View more
  247 in total

Review 1.  Transcranial near-infrared laser therapy applied to promote clinical recovery in acute and chronic neurodegenerative diseases.

Authors:  Paul A Lapchak
Journal:  Expert Rev Med Devices       Date:  2012-01       Impact factor: 3.166

2.  Construction, expression and refolding of a bifunctional fusion protein consisting of C-terminal 12-residue of hirudin-PA and reteplase.

Authors:  Ling Gao; Chun Zhang; Lingling Li; Lan Liang; Xuan Deng; Wutong Wu; Zhiguo Su; Rong Yu
Journal:  Protein J       Date:  2012-04       Impact factor: 2.371

Review 3.  Update in hospital medicine for the general internist 2010-2011.

Authors:  Romsai T Boonyasai; Daniel I Steinberg; Anneliese M Schleyer; Michelle M Mourad; Brian J Harte; Bradley A Sharpe
Journal:  J Gen Intern Med       Date:  2011-09-20       Impact factor: 5.128

Review 4.  Ultrasound- and microspheres-enhanced thrombolysis for stroke treatment: state of the art.

Authors:  Clotilde Balucani; Andrei V Alexandrov
Journal:  Curr Cardiol Rep       Date:  2010-01       Impact factor: 2.931

Review 5.  Management of acute ischemic stroke: time is brain.

Authors:  Marilyn M Rymner; Naveed Akhtar; Coleman Martin; Debbie Summers
Journal:  Mo Med       Date:  2010 Sep-Oct

Review 6.  Intra-arterial thrombectomy: does invasive treatment lead to better outcomes than intravenous thrombolysis alone?

Authors:  Laurel Cherian; Shawna Cutting; Sarah Song
Journal:  Curr Cardiol Rep       Date:  2015-10       Impact factor: 2.931

7.  Immune cell infiltration in malignant middle cerebral artery infarction: comparison with transient cerebral ischemia.

Authors:  Hannah X Chu; Hyun Ah Kim; Seyoung Lee; Jeffrey P Moore; Christopher T Chan; Antony Vinh; Mathias Gelderblom; Thiruma V Arumugam; Brad R S Broughton; Grant R Drummond; Christopher G Sobey
Journal:  J Cereb Blood Flow Metab       Date:  2013-12-11       Impact factor: 6.200

8.  Sonothrombolysis: an emerging modality for the treatment of acute ischemic and hemorrhagic stroke.

Authors:  Azita Soltani; Wayne M Clark; Douglas R Hansmann
Journal:  Transl Stroke Res       Date:  2011-04-15       Impact factor: 6.829

Review 9.  Translational MR Neuroimaging of Stroke and Recovery.

Authors:  Emiri T Mandeville; Cenk Ayata; Yi Zheng; Joseph B Mandeville
Journal:  Transl Stroke Res       Date:  2016-08-31       Impact factor: 6.829

Review 10.  The epigenetics of stroke recovery and rehabilitation: from polycomb to histone deacetylases.

Authors:  Jessica Elder; Mar Cortes; Avrielle Rykman; Justin Hill; Saravanan Karuppagounder; Dylan Edwards; Rajiv R Ratan
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.